Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 3:46 AM
Ignite Modification Date:
2025-12-25 @ 3:46 AM
NCT ID:
NCT07006402
Brief Summary:
This study is a randomized controlled trial and the purpose of the study is to determine the effects of reverse NAGs as compared to Ventro-cranial Translatoric Glides in upper thoracic spine hypomobility in terms of pain and range of motion.
Detailed Description:
OBJECTIVES:
The objectives of this study are :
1. To determine the effects of reverse NAGs as compared to ventrocranial translatoric glide on UPPER BACK PAIN in upper thoracic spine hypomobility.
2. To determine the effects of reverse NAGs as compared to ventrocranial translatoric glide on THORACIC ROM in upper thoracic spine hypomobility.
HYPOTHESIS:
Alternate Hypothesis:
1. There will be a statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of upper back pain in persons with upper thoracic hypo mobility (p\<0.05).
2. There will be a statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of thoracic ROM in persons with upper thoracic hypo mobility (p\<0.05).
NULL HYPOTHSIS :
1. There will be no statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of upper back pain in persons with upper thoracic hypo mobility (p\>0.05).
2. There will be no statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of thoracic ROM in persons with upper thoracic hypo mobility (p\>0.05).
RESEARCH DESIGN : Experimental study .Randomized control trail.
Study:
NCT07006402
Study Brief:
Protocol Section:
NCT07006402